Another cause of autoimmune hepatitis
β Scribed by Takeji Umemura; Yoh Zen; Yasuni Nakanuma; Kendo Kiyosawa
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 296 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
G (IgG) concentration was 5622 mg/dL (normal range: 870-1700), and anti-nuclear antibody titer (1:20480), anti-double-stranded DNA (>400 IU/mL), and smooth muscle antibody titer (1:40) were all abnormal. Infection with hepatitis A, B, and C; cytomegalovirus; and Epstein-Barr virus were excluded, and no drug use was noted. Ultrasonography, abdominal computed tomography, and magnetic resonance imaging showed no abnormalities of the extrahepatic .
π SIMILAR VOLUMES
We read with great interest the article by Cavazza et al., 1 who demonstrated that an advanced histological stage was the only risk factor associated with the development of hepatocellular carcinoma (HCC) in patients with primary biliary cirrhosis (PBC) from two European centers. Similar results wer
We read with interest the article by Hines et al. on impaired liver regeneration in T cell-mediated hepatitis. 1 The authors observed an interesting phenomenon that mice injected with concanavalin A (ConA) showed impaired liver regeneration 4 days after injection. They also found that important fact
US screening that were well-defined and identified in two US projections. By using these requirements, we avoided the inclusion of patients with coarse, ill-defined, previously present nodules that correspond to regenerative nodules within a cirrhotic liver. If we had included patients with several
In my humble opinion, to make strong recommendations when CPR is involved-when the only alternative to the procedure is deathrisks "playing God." We hope that our study will put to rest the idea that acutely ill patients do not want to make their own choices regarding end-of-life decisions, even th